AVR 0.90% $9.91 anteris technologies ltd

hsv2 final results, page-7

  1. 984 Posts.
    lightbulb Created with Sketch. 23
    The bio sector is littered with Phase 1, 2 & 3 trials where companies have spent millions of $ and failed to take the product to the next stage or commercialised.
    Just because we have Professor Fraser and his team working on this guarantees nothing and they might have a far greater understanding of how they expect the vac to work, but they don't know the results until they are released to them.

    I think AHZ has amazing products but let's keep it real, getting the vac to market is still a long shot. For me that's the chance of blue sky but I'm here for adapt.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.